CLINICAL TRIALS PROFILE FOR AFEGOSTAT
✉ Email this page to a colleague
Clinical Trials for Afegostat
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00433147 ↗ | A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy | Completed | Amicus Therapeutics | Phase 2 | This study was conducted to test the safety and tolerability of afegostat tartrate in participants with type 1 Gaucher disease already receiving enzyme replacement therapy. |
NCT00446550 ↗ | A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease | Completed | Amicus Therapeutics | Phase 2 | This study evaluated the safety and tolerability of afegostat tartrate in participants with type 1 Gaucher disease who were not receiving enzyme replacement therapy (ERT) or substrate reduction therapy (SRT). |
NCT00813865 ↗ | A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients | Completed | Amicus Therapeutics | Phase 2 | This study evaluated the long-term safety and efficacy of afegostat tartrate in participants with Gaucher disease who were enrolled in a previous Phase 2 study of afegostat tartrate. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Afegostat
Condition Name
Clinical Trial Locations for Afegostat
Trials by Country
Clinical Trial Progress for Afegostat
Clinical Trial Phase
Clinical Trial Sponsors for Afegostat
Sponsor Name